FANETTI, GIUSEPPE
FANETTI, GIUSEPPE
Universita' degli Studi di MILANO
IMRT versus 2D/3D conformal RT in oropharyngeal cancer: A review of the literature and meta-analysis
2021 D. Alterio, S.G. Gugliandolo, M. Augugliaro, G. Marvaso, S. Gandini, F. Bellerba, S.W. Russell-Edu, I. De Simone, M. Cinquini, A. Starzynska, M. Zaffaroni, A. Bacigalupo, G. Fanetti, S. Durante, S. Dicuonzo, R. Orecchia, B.A. Jereczek-Fossa
Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
2020 D. Alterio, S. Volpe, A. Bacigalupo, P. Bonomo, F. De Felice, F. Dionisi, I. D'Onofrio, E. D'Angelo, A. Di Rito, G. Fanetti, P. Franco, M. Maddalo, A. Merlotti, F. Micciché, E. Orlandi, F. Paiar, S. Ursino, M. Pepa, R. Corvò, N. Di Muzio, S. Magrini, E. Russi, G. Sanguineti, B. Jereczek-Fossa, V. Donato, D. Musio
Prognostic significance of neutrophil‐to‐lymphocyte ratio in HPV status era for oropharyngeal cancer
2020 G. Fanetti, D. Alterio, G. Marvaso, S. Gandini, D.P. Rojas, C. Gobitti, E. Minatel, A. Revelant, A. Caroli, C.M. Francia, O. Alessandro, M. Pepa, S.G. Gugliandolo, A. Starzyńska, J. Polesel, E. Vaccher, M. Cossu Rocca, M. Tagliabue, M. Ansarin, V. Lupato, V. Giacomarra, A. De Paoli, R. Orecchia, G. Franchin, B.A. Jereczek‐fossa
Erratum: Correction to: Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation (La Radiologia medica (2019) 124 1 (65-78))
2020 B.A. Jereczek-Fossa, A. Surgo, P. Maisonneuve, A. Maucieri, M.A. Gerardi, D. Zerini, G. Marvaso, D. Ciardo, S. Volpe, D.P. Rojas, G. Riva, O. Alessandro, S. Dicuonzo, G. Fanetti, P. Romanelli, A. Starzynska, F. Cattani, R. Cambria, C. Fodor, C. Garibaldi, C. Romano, O. De Cobelli, R. Orecchia
Intra- and inter-observer variability in breast tumour bed contouring and the controversial role of surgical clips
2019 G. Corrao, D.P. Rojas, D. Ciardo, G. Fanetti, S. Dicuonzo, M. Mantovani, M.A. Gerardi, V. Dell'Acqua, A. Morra, C. Fodor, V.E. Galimberti, P. Veronesi, F. Cattani, R. Orecchia, B.A. Jereczek-Fossa, M.C. Leonardi
Late toxicity of image-guided hypofractionated radiotherapy for prostate : non-randomized comparison with conventional fractionation
2019 B.A. Jereczek-Fossa, A. Surgo, P. Maisonneuve, A. Maucieri, M.A. Gerardi, D. Zerini, G. Marvaso, D. Ciardo, S. Volpe, D.P. Rojas, G. Riva, O. Alessandro, S. Dicuonzo, G. Fanetti, P. Romanelli, A. Starzyńska, F. Cattani, R. Cambria, C. Fodor, C. Garibaldi, C. Romanò, O. De Cobelli, R. Orecchia
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT)
2019 B.A. Jereczek-Fossa, D. Patricia Rojas, D. Zerini, C. Fodor, A. Viola, G. Fanetti, S. Volpe, R. Luraschi, A. Bazani, E. Rondi, F. Cattani, A. Vavassori, C. Garibaldi, S. Alessi, P. Pricolo, G. Petralia, G. Cozzi, O. De Cobelli, G. Musi, R. Orecchia, G. Marvaso, D. Ciardo
Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases
2018 G. Fanetti, G. Marvaso, D. Ciardo, A. Rese, R. Ricotti, E. Rondi, S. Comi, F. Cattani, D. Zerini, C. Fodor, O. de Cobelli, R. Orecchia, A. Jereczek Barbara
Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology
2017 D. Alterio, M. Cossu Rocca, W. Russell-Edu, S. Dicuonzo, G. Fanetti, G. Marvaso, L. Preda, S. Zorzi, E. Verri, F. Nole’, B.A. Jereczek-Fossa
No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy
2016 B.A. Jereczek-Fossa, D. Ciardo, S. Ferrario, P. Fossati, G. Fanetti, D. Zerini, D. Zannoni, C. Fodor, M.A. Gerardi, A. Surgo, M. Muto, R. Cambria, O. De Cobelli, R. Orecchia
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases
2015 F. Pietrantonio, V. Mazzaferro, R. Miceli, C. Cotsoglou, F. Melotti, G. Fanetti, F. Perrone, P. Biondani, C. Muscarà, M. Di Bartolomeo, J. Coppa, C. Maggi, M. Milione, E. Tamborini, F. de Braud
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma
2014 F. Pietrantonio, C. Maggi, G. Fanetti, R. Iacovelli, M. Di Bartolomeo, F. Ricchini, M. Deraco, F. Perrone, D. Baratti, S. Kusamura, E. Tamborini, A. Castano, P.V. Consonni, I. Bossi, C. Gavazzi, M. Milione, G. Pelosi, F. de Braud
Role of MGMT as biomarker in colorectal cancer
2014 A. Inno, G. Fanetti, M. Di Bartolomeo, S. Gori, C. Maggi, M. Cirillo, R. Iacovelli, F. Nichetti, A. Martinetti, F. de Braud, I. Bossi, F. Pietrantonio
Clinical outcome of HER2-positive breast cancer patients after failure on adjuvant trastuzumab : The potential of the time to relapse
2014 S. Di Cosimo, D. Serpico, L. Porcu, L. Molino, G. Fanetti, V. Torri, F. de Braud
A review on biomarkers for prediction of treatment outcome in gastric cancer
2013 F. Pietrantonio, F. De Braud, V. Da Prat, F. Perrone, M.A. Pierotti, M. Gariboldi, G. Fanetti, P. Biondani, A. Pellegrinelli, I. Bossi, M. Di Bartolomeo
Reversible bilateral blepharoptosis following oxaliplatin infusion: a case report and literature review
2013 G. Fanetti, L.A.M. Ferrari, F. Pietrantonio, R. Buzzoni
Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients
2013 F. Pietrantonio, P. Biondani, M. Milione, F. Melotti, G. Bertarelli, F. Perrone, F. De Braud, L. Mariani, G. Fanetti, D. Cortinovis, M. Di Bartolomeo
Single agent panitumumab in kras wild-type metastatic colorectal cancer patients following cetuximab-based regimens
2013 F. Pietrantonio, F. Perrone, P. Biondani, C. Maggi, A. Lampis, C. Bertan, F. Venturini, L. Tondulli, D. Ferrari, V. Ricci, F. Villa, G. Barone, N. Bianco, A. Ghidini, I. Bossi, G. Fanetti, M.D. Bartolomeo, F. De Braud
Role of BAX for outcome prediction in gastrointestinal malignancies
2013 F. Pietrantonio, P. Biondani, E. Ciurlia, G. Fanetti, A. Tessari, G. Bertarelli, I. Bossi, V. Musella, F. Melotti, M.D. Bartolomeo, F. Valvo, A. Pellegrinelli, M. Milione, F. Perrone, F. De Braud